Literature DB >> 21583705

2-Phenyl-5-(trifluoro-meth-yl)pyrazol-3(2H)-one.

Hugo Gallardo1, Edivandro Girotto, Adailton J Bortoluzzi, Geovana G Terra.   

Abstract

The title compound, C(10)H(7)F(3)N(2)O, is an analogue of pyrazolone derivatives with potential analgesic and anti-inflammatory properties. Its mol-ecular structure consists of phenyl and pyrazol-3(2H)-one units with a dihedral angle between the mean planes of the rings of 33.0 (1)°. The crystal structure is stabilized by an inter-molecular hydrogen bond between the N-H group and the carbonyl O atom of the pyrazol-3(2H)-one ring which links the mol-ecules into supra-molecular C(5) chains along [001] and by weak π-π stacking inter-actions between the phenyl rings [centroid-centroid distance = 3.881 (2) Å]. The F atoms are disordered over two positions with refined site occupancies of 0.768(11) and 0.232(11).

Entities:  

Year:  2009        PMID: 21583705      PMCID: PMC2977152          DOI: 10.1107/S1600536809029419

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the analgesic properties of pyrazolones, see: Mehlisch (1983 ▶); Schnitzer (2003 ▶). For the biological activity of some pyrazolone derivatives, see: Pavlov et al. (1998 ▶). For the pharmacological properties of pyrazolone deriavtives, see: Kees et al. (1996 ▶). For related structures, see: Belmar et al. (2006a ▶,b ▶); Pérez et al. (2005 ▶). For metal complexes, see: Hyun-Shin et al. (2008 ▶); Gallardo et al. (2004 ▶); Meyer et al. (1998 ▶). For the synthesis of pyrazolones, see: Nakagawa et al. (2006 ▶); Belmar et al. (2001 ▶); Bartulín et al. (1994 ▶). For hydrogen-bond motifs, see: Bernstein et al. (1995 ▶).

Experimental

Crystal data

C10H7F3N2O M = 228.18 Monoclinic, a = 5.8409 (5) Å b = 15.2454 (14) Å c = 11.2291 (17) Å β = 92.403 (9)° V = 999.0 (2) Å3 Z = 4 Mo Kα radiation μ = 0.14 mm−1 T = 293 K 0.46 × 0.40 × 0.20 mm

Data collection

Enraf–Nonius CAD-4 diffractometer Absorption correction: none 2262 measured reflections 2157 independent reflections 1141 reflections with I > 2σ(I) R int = 0.024 3 standard reflections every 200 reflections intensity decay: 1%

Refinement

R[F 2 > 2σ(F 2)] = 0.060 wR(F 2) = 0.188 S = 1.03 2157 reflections 173 parameters 81 restraints H-atom parameters constrained Δρmax = 0.30 e Å−3 Δρmin = −0.32 e Å−3 Data collection: CAD-4 Software (Enraf–Nonius, 1989 ▶); cell refinement: SET4 in CAD-4 Software; data reduction: HELENA (Spek, 1996 ▶); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: PLATON (Spek, 2009 ▶); software used to prepare material for publication: SHELXL97. Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536809029419/bx2225sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536809029419/bx2225Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C10H7F3N2OF(000) = 464
Mr = 228.18Dx = 1.517 Mg m3
Monoclinic, P21/cMelting point = 464–465 K
Hall symbol: -P 2ybcMo Kα radiation, λ = 0.71073 Å
a = 5.8409 (5) ÅCell parameters from 25 reflections
b = 15.2454 (14) Åθ = 3.2–13.8°
c = 11.2291 (17) ŵ = 0.14 mm1
β = 92.403 (9)°T = 293 K
V = 999.0 (2) Å3Irregular, colourless
Z = 40.46 × 0.40 × 0.20 mm
Enraf–Nonius CAD-4 diffractometerRint = 0.024
Radiation source: fine-focus sealed tubeθmax = 27.0°, θmin = 2.3°
graphiteh = −7→7
ω–2θ scansk = −19→0
2262 measured reflectionsl = −14→0
2157 independent reflections3 standard reflections every 200 reflections
1141 reflections with I > 2σ(I) intensity decay: 1%
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.060Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.188H-atom parameters constrained
S = 1.03w = 1/[σ2(Fo2) + (0.0843P)2 + 0.3445P] where P = (Fo2 + 2Fc2)/3
2157 reflections(Δ/σ)max = 0.001
173 parametersΔρmax = 0.30 e Å3
81 restraintsΔρmin = −0.32 e Å3
Experimental. The title compound was synthesized by the condensation of ethyl 4,4,4-trifluoroacetoacetate (5.0?g, 27.2?mmol) in acetic acid (50?ml) with phenylhydrazine (2.9?g, 27.2?mmol) which was added drop wise, with stirring for 3?h. The solvent was removed by evaporation; resulting crude solid was extracted with AcOEt. The organic layer was washed with saturated aqueous NaHCO3 and water, then brine, and evaporation the solvent. The compound, obtained as colorless single crystals, was recrystallized using ethylacetate and n-hexane (2:1) and was suitable for X-ray structure determination. Yield 76% mp: 191–192 °C, lit. 195–196 °C (Nakagawa et al., 2006). 1H-NMR (DMSO, 400?MHz, d, p.p.m.) 12,42 (1H, s), 7,70 (2H, d, J = 8?Hz), 7,49 (2H, t, J = 8?Hz), 7,36 (1H, t, J = 8?Hz), 5,92 (1H, s). 13C-NMR (DMSO, 400?MHz, d, p.p.m.) 153,68 (C5), 140,21 (C3), 13,70 (C6), 129,07 (C10; C8), 127,18 (C9), 122,25 (C11; C7), 119,98 (C12), 85,53 (C4).
xyzUiso*/UeqOcc. (<1)
N10.2789 (5)0.78258 (17)0.98039 (19)0.0486 (7)
N20.3999 (5)0.73266 (19)0.90418 (19)0.0534 (7)
H20.37290.74050.82700.064*
C30.5425 (6)0.6863 (2)0.9721 (3)0.0535 (8)
C40.5221 (6)0.7045 (2)1.0923 (3)0.0567 (9)
H40.60520.68011.15660.068*
C50.3528 (6)0.7661 (2)1.0950 (2)0.0523 (8)
C60.1101 (5)0.8436 (2)0.9370 (2)0.0471 (8)
C70.1383 (6)0.8843 (2)0.8282 (2)0.0582 (9)
H70.26710.87300.78470.070*
C8−0.0280 (7)0.9420 (3)0.7854 (3)0.0730 (11)
H8−0.01110.96940.71230.088*
C9−0.2193 (7)0.9594 (3)0.8499 (4)0.0745 (11)
H9−0.33040.99830.82040.089*
C10−0.2439 (6)0.9189 (3)0.9575 (3)0.0691 (10)
H10−0.37150.93091.00160.083*
C11−0.0805 (6)0.8604 (2)1.0010 (3)0.0583 (9)
H11−0.09940.83231.07350.070*
C120.7009 (8)0.6240 (3)0.9172 (3)0.0712 (11)
F10.7641 (13)0.6502 (4)0.8115 (4)0.118 (3)0.768 (11)
F1'0.617 (3)0.5831 (17)0.826 (2)0.129 (8)0.232 (11)
F20.8938 (12)0.6159 (7)0.9809 (5)0.129 (3)0.768 (11)
F2'0.884 (4)0.6549 (11)0.882 (3)0.141 (9)0.232 (11)
F30.6134 (13)0.5470 (4)0.9008 (9)0.144 (3)0.768 (11)
F3'0.760 (5)0.5604 (14)0.9906 (13)0.104 (6)0.232 (11)
O10.2602 (4)0.81041 (16)1.18269 (16)0.0686 (8)
U11U22U33U12U13U23
N10.0599 (16)0.0617 (17)0.0244 (11)0.0019 (14)0.0042 (10)−0.0008 (11)
N20.0666 (17)0.0714 (18)0.0225 (11)0.0001 (14)0.0044 (11)−0.0034 (11)
C30.062 (2)0.062 (2)0.0374 (16)0.0015 (17)0.0057 (15)0.0011 (15)
C40.068 (2)0.068 (2)0.0336 (15)0.0072 (19)0.0006 (14)0.0062 (15)
C50.070 (2)0.063 (2)0.0242 (14)−0.0023 (18)0.0033 (13)0.0040 (13)
C60.0554 (19)0.0511 (18)0.0343 (15)−0.0052 (16)−0.0026 (13)−0.0028 (13)
C70.072 (2)0.067 (2)0.0360 (15)−0.0042 (19)0.0003 (15)0.0052 (15)
C80.093 (3)0.068 (3)0.056 (2)−0.011 (2)−0.015 (2)0.0164 (18)
C90.075 (3)0.063 (2)0.083 (3)0.001 (2)−0.022 (2)0.005 (2)
C100.059 (2)0.073 (2)0.075 (2)0.001 (2)−0.0004 (18)−0.004 (2)
C110.062 (2)0.066 (2)0.0470 (18)−0.0056 (19)0.0017 (16)0.0011 (16)
C120.078 (3)0.083 (3)0.054 (2)0.010 (2)0.018 (2)−0.003 (2)
F10.142 (6)0.152 (5)0.064 (3)0.052 (4)0.050 (3)0.008 (3)
F1'0.083 (11)0.172 (19)0.129 (14)0.035 (11)−0.038 (10)−0.112 (12)
F20.100 (4)0.187 (7)0.099 (4)0.068 (4)−0.016 (3)−0.030 (4)
F2'0.105 (13)0.127 (13)0.20 (2)−0.035 (10)0.083 (14)−0.071 (15)
F30.164 (6)0.077 (3)0.197 (8)−0.008 (3)0.088 (6)−0.041 (4)
F3'0.133 (15)0.104 (11)0.074 (8)0.059 (10)−0.003 (9)−0.004 (8)
O10.0983 (19)0.0804 (17)0.0276 (11)0.0248 (15)0.0078 (11)−0.0044 (10)
N1—C51.363 (3)C8—C91.382 (6)
N1—N21.365 (3)C8—H80.9300
N1—C61.426 (4)C9—C101.371 (5)
N2—C31.312 (4)C9—H90.9300
N2—H20.8825C10—C111.381 (5)
C3—C41.388 (4)C10—H100.9300
C3—C121.479 (5)C11—H110.9300
C4—C51.366 (5)C12—F2'1.247 (14)
C4—H40.9300C12—F1'1.279 (13)
C5—O11.327 (4)C12—F31.291 (7)
C6—C111.374 (4)C12—F3'1.309 (13)
C6—C71.387 (4)C12—F21.315 (6)
C7—C81.381 (5)C12—F11.320 (5)
C7—H70.9300
C5—N1—N2109.7 (3)C9—C8—H8119.6
C5—N1—C6129.0 (2)C10—C9—C8119.5 (4)
N2—N1—C6121.2 (2)C10—C9—H9120.3
C3—N2—N1105.6 (2)C8—C9—H9120.3
C3—N2—H2136.6C9—C10—C11120.4 (4)
N1—N2—H2117.7C9—C10—H10119.8
N2—C3—C4112.3 (3)C11—C10—H10119.8
N2—C3—C12119.8 (3)C6—C11—C10119.9 (3)
C4—C3—C12127.9 (3)C6—C11—H11120.1
C5—C4—C3104.5 (3)C10—C11—H11120.1
C5—C4—H4127.7F2'—C12—F1'103.5 (9)
C3—C4—H4127.7F2'—C12—F3'105.9 (9)
O1—C5—N1119.0 (3)F1'—C12—F3'103.0 (9)
O1—C5—C4133.2 (3)F3—C12—F2108.5 (5)
N1—C5—C4107.9 (3)F3—C12—F1105.8 (5)
C11—C6—C7120.4 (3)F2—C12—F1104.6 (5)
C11—C6—N1120.4 (3)F2'—C12—C3116.7 (8)
C7—C6—N1119.2 (3)F1'—C12—C3114.9 (7)
C8—C7—C6118.9 (3)F3—C12—C3113.1 (4)
C8—C7—H7120.5F3'—C12—C3111.6 (7)
C6—C7—H7120.5F2—C12—C3111.8 (4)
C7—C8—C9120.8 (3)F1—C12—C3112.5 (4)
C7—C8—H8119.6
C5—N1—N2—C30.6 (4)C6—C7—C8—C90.3 (5)
C6—N1—N2—C3178.3 (3)C7—C8—C9—C100.0 (6)
N1—N2—C3—C4−0.6 (4)C8—C9—C10—C11−0.7 (6)
N1—N2—C3—C12179.7 (3)C7—C6—C11—C10−0.7 (5)
N2—C3—C4—C50.4 (4)N1—C6—C11—C10−179.4 (3)
C12—C3—C4—C5180.0 (4)C9—C10—C11—C61.1 (5)
N2—N1—C5—O1178.1 (3)N2—C3—C12—F2'84.0 (18)
C6—N1—C5—O10.6 (5)C4—C3—C12—F2'−95.6 (18)
N2—N1—C5—C4−0.4 (4)N2—C3—C12—F1'−37.5 (17)
C6—N1—C5—C4−177.9 (3)C4—C3—C12—F1'143.0 (17)
C3—C4—C5—O1−178.1 (4)N2—C3—C12—F3−88.1 (7)
C3—C4—C5—N10.0 (4)C4—C3—C12—F392.3 (7)
C5—N1—C6—C11−35.3 (5)N2—C3—C12—F3'−154.2 (17)
N2—N1—C6—C11147.5 (3)C4—C3—C12—F3'26.3 (18)
C5—N1—C6—C7146.0 (3)N2—C3—C12—F2149.0 (7)
N2—N1—C6—C7−31.2 (4)C4—C3—C12—F2−30.5 (9)
C11—C6—C7—C80.0 (5)N2—C3—C12—F131.7 (7)
N1—C6—C7—C8178.7 (3)C4—C3—C12—F1−147.9 (5)
D—H···AD—HH···AD···AD—H···A
N2—H2···O1i0.881.892.667 (3)146
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N2—H2⋯O1i0.881.892.667 (3)146

Symmetry code: (i) .

  9 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 2.  Review of the comparative analgesic efficacy of salicylates, acetaminophen, and pyrazolones.

Authors:  D R Mehlisch
Journal:  Am J Med       Date:  1983-11-14       Impact factor: 4.965

3.  Hydroxyl radical scavenging by edaravone derivatives: Efficient scavenging by 3-methyl-1-(pyridin-2-yl)-5-pyrazolone with an intramolecular base.

Authors:  Hidehiko Nakagawa; Ryo Ohyama; Ayako Kimata; Takayoshi Suzuki; Naoki Miyata
Journal:  Bioorg Med Chem Lett       Date:  2006-09-25       Impact factor: 2.823

4.  Bis{1-n-hexyl-3-methyl-4-[1-(phenylimino)propyl]-1H-pyrazol-5-olato}copper(II): a new copper(II) complex with a chelating alkylpyrazolone-based enamine.

Authors:  Fredy R Pérez; Julio Belmar; Claudio Jiménez; Yanko Moreno; Patricio Hermosilla; Ricardo Baggio
Journal:  Acta Crystallogr C       Date:  2005-05-31       Impact factor: 1.172

5.  An oximino tautomer of 1-n-decyl-4-hydroxyimino-3-methyl-1H-pyrazol-5(4H)-one.

Authors:  Julio Belmar; Claudio Jiménez; Leandro Ortiz; María Teresa Garland; Ricardo Baggio
Journal:  Acta Crystallogr C       Date:  2006-01-14       Impact factor: 1.172

6.  A unique tautomer of 1-n-hexyl-3-phenyl-1H-pyrazol-5-ol.

Authors:  Julio Belmar; Claudio Jiménez; C Ruiz-Pérez; F S Delgado; Ricardo Baggio
Journal:  Acta Crystallogr C       Date:  2006-09-12       Impact factor: 1.172

Review 7.  The new analgesic combination tramadol/acetaminophen.

Authors:  T Schnitzer
Journal:  Eur J Anaesthesiol Suppl       Date:  2003

8.  New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones.

Authors:  K L Kees; J J Fitzgerald; K E Steiner; J F Mattes; B Mihan; T Tosi; D Mondoro; M L McCaleb
Journal:  J Med Chem       Date:  1996-09-27       Impact factor: 7.446

9.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  9 in total
  3 in total

1.  1-(5-Hydroxy-1-phenyl-3-trifluoromethyl-1H-pyrazol-1-yl)ethanone.

Authors:  Hugo Gallardo; Edivandro Girotto; Adailton J Bortoluzzi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-12-09

2.  1,3-Diphenyl-4,5-dihydro-1H-pyrazol-5-one.

Authors:  Thomas C Baddeley; Solange M S V Wardell; Edward R T Tiekink; James L Wardell
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-10

3.  N'-[(4Z)-1-(3-Methyl-5-oxo-1-phenyl-4,5-di-hydro-1H-pyrazol-4-yl-idene)hex-yl]benzene-sulfono-hydrazide.

Authors:  Nkechinyere N Ukwueze; Pius O Ukoha; Oguejiofo T Ujam; Jonnie N Asegbeloyin; Tania Groutso
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.